Previous Article | Next Article 
Journal of Clinical Microbiology, March 1998, p. 802-806, Vol. 36, No. 3
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Simultaneous Identification of Antibodies to
Brucella abortus and Staphylococcus aureus in
Milk Samples by Flow Cytometry
Domenico
Iannelli,1,*
Letizia
D'Apice,2
Domenico
Fenizia,2
Luigi
Serpe,2
Carlo
Cottone,1
Maurizio
Viscardi,1 and
Rosanna
Capparelli1
Chair of Immunology, School of
Agriculture,1 and
Istituto
Zooprofilattico Sperimentale,2 Portici, 80055 Naples, Italy
Received 16 June 1997/Returned for modification 18 August
1997/Accepted 19 December 1997
 |
ABSTRACT |
Two flow cytometric assays are described herein. The single
cytometric test (SCT) detects antibodies to either Brucella
abortus or Staphylococcus aureus in the serum or milk
of a cow or water buffalo. The double cytometric test (DCT) detects
both anti-B. abortus and anti-S. aureus
antibodies concurrently. In the SCT, the sample to be tested is
incubated in succession with the antigen (either B. abortus
or S. aureus) and the proper secondary antiserum (fluorescein isothiocyanate-labelled rabbit anti-cow immunoglobulin antiserum or rabbit anti-water buffalo immunoglobulin antiserum). In
the DCT, the sample to be tested is incubated first with B. abortus and S. aureus antigens and then with the
secondary antiserum. The B. abortus antigen used in the DCT
is covalently bound to 3-µm-diameter latex particles. The difference
in size between B. abortus and S. aureus
permits the establishment of whether the antibodies are directed
against one, the other, or both antigens. When compared to the
complement fixation test, the SCT and DCT each show a specificity and a
sensitivity of 100%. The SCT has been used previously to detect
anti-S. aureus antibodies. Here its use is extended to the
detection of anti-B. abortus antibodies. The DCT is
described here for the first time. The DCT appears to be useful for
large-scale brucellosis eradication programs. It offers the possibility
of using one test to identify animals that are serologically positive
for both B. abortus and S. aureus.
 |
INTRODUCTION |
Brucellosis (1, 9, 10)
and mastitis (12, 13, 20) are economically important
diseases for the dairy industry. Brucellosis is relevant also as a
zoonotic disease (23, 24). Staphylococcus aureus
is the most frequent cause of bovine (12) and water buffalo
(6) mastitis, and Brucella abortus is the most
common cause of bovine (1) and water buffalo (19)
brucellosis. In Italy, during 1995, the incidence rates of brucellosis
in cattle and water buffalo were about 0.5 and 3% of tested animals,
respectively; in the same year, the incidence rates of clinical
mastitis among lactating cattle and water buffaloes were 25 and 10%,
respectively. These data refer to animals tested as part of the ongoing
national program for brucellosis eradication in Italy (14).
Schemes for eradication of brucellosis are based on the serological
identification and subsequent elimination of animals displaying the
presence of antibodies. The commonly used serological
tests
agglutination, complement fixation test (CFT), and enzyme-linked
immunosorbent assay
all have both advantages and disadvantages
(1, 3, 4). The laboratory diagnosis of mastitis is based on
the somatic-cell count in milk (California mastitis test) and on
culture of the bacterium. The California mastitis test is an indicator
of the state of inflammation of the udder, characterized by an increase in the number of neutrophils and epithelial cells shed by the mammary
gland. The counting of somatic cells present in the milk is laborious
and does not provide information on the cause of inflammation
(17). It is possible that cultures of milk samples which are
positive in this test will be negative for pathogens (18).
Bacterial cultures, on the other hand, can be time-consuming and
expensive (7, 18). Recently, antibodies to S. aureus were detected in milk by flow cytometry (6). The
present paper demonstrates that the same technique can simultaneously
detect antibodies to B. abortus and S. aureus in
milk.
 |
MATERIALS AND METHODS |
Bacteria.
S. aureus Wood 46 and vaccine strain 19 of
B. abortus were used as antigens. S. aureus was
grown on Baird-Parker medium or Trypticase soy agar with 5% sheep
blood; B. abortus was cultured on tryptose agar (Difco
Laboratories, Detroit, Mich.). The smooth phenotype of B. abortus was determined as described elsewhere (1).
Antisera.
Rabbit anti-water buffalo immunoglobulin antiserum
(R
WBFITC) was prepared and labelled with fluorescein
isothiocyanate (FITC) as described previously (6).
FITC-labelled rabbit anti-cow immunoglobulin antiserum
(R
CFITC) was purchased from Sigma (Milan, Italy).
CFT.
The CFT was carried out as described elsewhere
(14).
SCT.
In the single cytometric test (SCT), anti-B.
abortus or anti-S. aureus antibodies were bound to the
corresponding antigen and then detected by flow cytometry with
R
WBFITC (in the case of samples from water buffaloes) or
R
CFITC (in the case of samples from cows). Bacteria
(S. aureus or B. abortus) were counted with the
flow cytometer and then suspended in 0.15 M phosphate-buffered saline,
pH 7.2 (PBS), at 108/ml. Ten microliters of bacterial
suspension (containing approximately 106 S. aureus or B. abortus cells) was incubated for 3 h
with 50 µl of the milk or serum sample. Milk samples were defatted by centrifugation (1 min at 6,000 × g) and tested
undiluted; serum samples were instead diluted 10
1,
10
2, and 10
3 with PBS. Following incubation
with the milk or serum sample, bacteria were washed twice with PBS
containing 1% bovine serum albumin (PBS-BSA) and incubated for 1 h with 50 µl of either R
CFITC or
R
WBFITC diluted 5 × 10
3 with
PBS-BSA. Titration experiments established that at this dilution both
reagents gave maximal specific fluorescence. Bacteria (S. aureus or B. abortus) were washed again with PBS-BSA
and analyzed with the flow cytometer. The instrument (FACScan; Becton
Dickinson Immunocytometry Systems, San Jose, Calif.) was equipped with
a 15-mW, air-cooled, 488-nm-wavelength argon ion laser. FITC
fluorescence was collected through a 530/30-nm bandpass filter.
For each sample, the data of 10,000 events were analyzed by using
Consort 32 software (Hewlett-Packard, Sunnyvale, Calif.). No gates were
set around the particles. Results are presented as the mean channel of
fluorescence for the treated sample minus the mean channel of
fluorescence for the control tubes (incubated with PBS). When PBS was
replaced with normal milk or normal serum, the mean values of control
tubes were slightly more variable (two to three channels higher or
lower). Logarithmic units (log10 U) were transformed into
linear channels (LC) by using the formula LC = total number of
channels/number of log decades × log10 U. The total
number of channels and the number of log decades of the instrument were
1,024 and 4, respectively.
DCT.
The double cytometric test (DCT) detects anti-S.
aureus and anti-B. abortus antibodies simultaneously by
flow cytometry. About 107 latex particles, 3 µm in
diameter (Polyscience Ltd., Eppelheim, Germany), were incubated with 1 ml of 0.1% 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (Sigma) for
4 h at room temperature. Particles were washed with PBS and
incubated overnight at 4°C with 107 bacteria (B. abortus) resuspended in 1 ml of 0.025 M
2-(N-morpholino)ethanesulfonic acid (Sigma). Bacteria
adhering to the latex particles were washed with PBS, saturated with
PBS-BSA for 30 min at 37°C, and resuspended in 1 ml of PBS-BSA
containing 0.1% NaN3. Fifty microliters of this suspension
(B. abortus covalently bound to latex particles) and 50 µl
of an S. aureus suspension (at about 107
bacteria/ml of PBS-BSA) were incubated for 3 h at room temperature under agitation with the milk sample being tested (undiluted and previously defatted by centrifugation). Bacteria were washed twice with
PBS-BSA and incubated for 1 h with 50 µl of
R
WBFITC or R
CFITC diluted 5 × 10
3. Forward scatter (FSC) and side scatter (SSC) were
analyzed on a linear scale, and FITC fluorescence was analyzed on a
logarithmic scale. FSC correlates with the size of the particles, and
SSC correlates with their granularity (fine internal structure). In the
analysis, gates were set around B. abortus (R1) and S. aureus (R2) on the basis of their FSC and SSC. Histogram analysis
was performed on FITC fluorescence for both R1 and R2. The mean channel was calculated as described for the SCT.
Statistics.
Intra- and interassay coefficients of variation
were measured by testing blood and milk samples with known low and high
titers in triplicate on the same day (intra-assay) and on four
different days (interassay). The correlation coefficients were
calculated as described elsewhere (22).
Specificity and sensitivity.
Sensitivity and specificity
were calculated as described elsewhere (3).
Sampling.
Individual serum samples from 150 lactating cows
and as many lactating water buffaloes were tested for the presence of
B. abortus and S. aureus antibodies by SCT, DCT,
and CFT; milk samples from the same animals were tested by SCT and DCT.
One hundred of these samples were collected from herds in which no
cases of either brucellosis or mastitis had been reported during the
previous 2 to 5 years (control population), and 50 were collected from herds with reported cases of brucellosis and/or mastitis. Also included
in the study were serum samples from 30 water buffaloes vaccinated 2 to
4 months earlier with B. abortus (19). All milk and blood samples were collected within a period of about 2 weeks and
tested blindly, that is, without knowledge of the health of the animals
from which they were collected.
 |
RESULTS |
Identification of anti-B. abortus antibodies in
milk and serum by SCT.
Serum samples were tested by SCT and CFT;
milk samples displayed anticomplement activity and were therefore
tested by SCT only. The levels of discrimination between positive and
negative samples with respect to the presence of antibodies against
B. abortus were set at the mean channel for the
negative-control population plus twice the standard deviation (5,
16) for the SCT and at <20 international complement fixation
units (ICFU)/ml for the CFT (1). ICFU measure the titer of
anti-B. abortus antibodies present in the sample to be
tested, in reference to a standard serum taken to contain
103 ICFU/ml (1).
By these criteria, the two techniques gave fully concordant results for
the control population of cows and of water buffaloes, with milk and
serum samples all being negative (Table
1).
Among the animals from herds with a high incidence of brucellosis, four
water buffaloes gave contrasting results; while no anti-B.
abortus antibodies were detected in the sera of these subjects by
CFT, antibodies were detected in the serum and milk samples by SCT
(Table 1). Bacterial cultures established the presence of B. abortus in the milk of the four animals, and blood samples taken 1 month later were positive in the CFT.
The two techniques also yielded discrepant results for the group of
vaccinated animals; 10 of 30 subjects were CFT negative but SCT
positive. One month later, these 10 animals all were positive by CFT.
No animal was found to be positive by CFT and negative by SCT. The
intra- and interassay coefficients of variation for the SCT were 4 and
5%, respectively, and were not influenced by the level of the
antibodies.
Properties of the SCT.
The levels of anti-B.
abortus antibodies in the serum and in the milk of each animal
were almost identical (Fig. 1). Among the
300 tested animals (150 cows and 150 water buffaloes), the individual
difference between the milk and serum antibody levels was always less
than 4% (i.e., within the range of the intra-assay coefficient of
variation) and the relative correlation coefficient was especially high
(r = 1; P < 0.001) for both cows and
water buffaloes (Fig. 2). More
importantly, the antibody level could be established by testing a
single dilution of the milk or serum sample (Fig. 1). This
characteristic was observed over the whole range (three logarithmic
decades) of mean channel values (Fig. 1). When the antibody levels
measured by SCT and by CFT were compared (Fig.
3), a very high correlation coefficient
(r = 0.99 for both cows and water buffaloes;
P < 0.001) was found, indicating that the antibody
level, as measured by SCT, can be easily converted into ICFU and vice
versa.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 1.
Mean channel values for milk (curves 1, 3, 5, and 7) and
serum (curves 2, 4, 6, and 8) samples from four different animals. The
mean channel values for the curves were as follows: curve 1, 241; curve
2, 238; curve 3, 425; curve 4, 427; curve 5, 590; curve 6, 588; curve
7, 758; and curve 8, 762. Abscissa, mean channel; ordinate, number of
events.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 2.
Correlation between serum and milk mean channel values
for water buffaloes ( ) and cows ( ) as measured by SCT. Animals
were divided into the following groups: animals with serum and milk
mean channel values ± standard deviations of 76 ± 1.7 (group I), 190 ± 3.6 (group II), 240 ± 6 (group III),
341 ± 7.8 (group IV), 425 ± 9.7 (group V), 578 ± 8.4 (group VI), and 757 ± 9.4 (group VII). n, number of animals
tested.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
Correlation between mean channel values, as measured by
SCT, and ICFU, as measured by CFT, for water buffaloes ( ) and cows
( ). Animals were divided into the following groups: animals with
mean channel (± standard deviation) and ICFU values of 77 ± 1.5 and <20 (group I), 187 ± 3.5 and 20 (group II), 237 ± 5 and 40 (group III), 345 ± 6 and 80 (group IV), 430 ± 7 and
160 (group V), 588 ± 8 and 320 (group VI), and 763 ± 9.8 and 640 (group VII). n, number of animals tested.
|
|
Identification of anti-S. aureus in milk by SCT.
The level of discrimination between positive and negative samples with
respect to the presence of anti-S. aureus antibodies was set
by the same criterion adopted for anti-B. abortus antibodies (the mean channel of the control population plus twice the standard deviation). The 200 samples (100 cow and 100 water buffalo samples) representing the control population were all negative. Of the 100 samples derived from farms with a high incidence of mastitis, 65 (35 cow and 30 water buffalo samples) were positive (Table 2); the remaining 35 samples were
negative. Bacterial cultures detected the presence of S. aureus in 40 of the positive samples; 1 month later, S. aureus was isolated from the remaining 25 samples.
Simultaneous detection of anti-B. abortus and
anti-S. aureus antibodies by DCT.
The potential of the
cytometer to carry out two immunofluorescence measurements at the same
time was exploited to detect antibodies against B. abortus
and S. aureus simultaneously. For this purpose, the size of
one of the two antigens (B. abortus) was altered by covalently binding it to latex particles. With this artifice, the
antibodies against the two bacteria could be identified simultaneously (Fig. 4). Milk samples from 300 animals
were tested by SCT and DCT. The fluorescence intensities (the mean
channel values) obtained with the two assays were very similar (Fig. 4
and Table 3). This result indicates that
in the DCT the two immunofluorescence signals do not influence each
other at all.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 4.
(A) Dot plot showing FSC (abscissa) versus SSC
(ordinate) of S. aureus (R1) and B. abortus (R2);
the latter antigen was covalently bound to latex particles. The mean
channel values of B. abortus antibody curves measured by SCT
(B) and DCT (D) were practically the same. Analogously, the mean
channel values of S. aureus antibody curves remained
unchanged, whether measured by SCT (C) or DCT (E). A DCT was developed
by using as antigens the bacteria shown in panel A. DCT and SCT were
carried out on the same milk sample. Curve 1, control (no milk); curves
2 to 5, activity curves. Mean channel values of curves 2 to 5 were as
follows: curve 2, 424; curve 3, 828; curve 4, 418; and curve 5, 835. Abscissa, mean channel; ordinate, number of events.
|
|
 |
DISCUSSION |
One of the objectives of the present study was to validate the
capacity of SCT to detect the presence of anti-B. abortus
antibodies in the serum. For this purpose, SCT was compared with CFT,
the reference test for brucellosis in Italy (14). This
comparison (Table 1) established that SCT and CFT display the same
specificity (100%) but that SCT has a higher sensitivity (100%,
versus 74.5% for CFT).
SCT was validated also with respect to its capacity to detect
antibodies against S. aureus in the milk. In this case, SCT was compared with bacterial culture. In milk samples, the presence of
antibodies, as detected by SCT, invariably corresponded to the presence
of the pathogen, but SCT gave an earlier response in 25 (25%) of the
100 cases (Table 2). Thus, the present study extends previous results
(6) and confirms the validity of SCT as a specific
serological test for mastitis. To the knowledge of the authors, the SCT
is the only specific test for mastitis available at present.
The next step was to ascertain whether anti-B. abortus
antibodies could be reliably detected in the milk in addition to the serum. The result was clear: whenever antibodies were present in the
serum, they were also present in the milk, at the same level (Fig. 2).
We then moved on to see whether antibodies to the two pathogens could
be identified concurrently.
The fluorescence intensities (the mean channel values) of milk samples
determined by SCT and by DCT were for all practical purposes the same
(Table 3), demonstrating that the two antibodies could be identified
concurrently without any loss of sensitivity.
In this study, B. abortus 19 was chosen as the antigen since
it was readily available. However, unpublished results of this laboratory indicate that other strains (544 [ATCC 23448] and B3196 [ATCC 23452]) with a smooth phenotype perform equally well. The use
of protein A-deficient S. aureus strain Wood 46 as the
antigen was instead dictated by evidence (6) that protein
A-positive strains bind immunoglobulin on the bacterial surface and
reduce the sensitivity of the assay. This strain is also readily
available (ATCC 10832).
In addition to the ability, unique to the DCT, to identify antibodies
against two distinct targets (and potentially more than two)
simultaneously, the methods described here (SCT and DCT) are ideal for
quantitating antibodies. While in the CFT (and in other methods as
well) a series of dilutions must be tested to establish the antibody
level, in the SCT and DCT a single dilution is sufficient (Fig. 4).
Under standardized testing conditions, a close correlation can be found
between mean fluorescence and antibody level (Fig. 3). Mean channel
values can thus be transformed into ICFU, and individual samples can be
compared with each other or with a standard. Another useful feature of
these techniques is represented by the high reproducibility of the
results. Coefficients of variation as low as 4 to 5% can be attained.
This is possible because the methods permit the use of unchanged gate
and marker settings throughout the experiments, i.e., optimized and
uniform testing conditions for all samples. The SCT and DCT also
require only short incubation times. More than 50 samples (and possibly many more) can be tested in one workday. Thus, these methods have the
essential requirements for routine testing.
In the absence of repeated serological follow-up of the animals, it is
difficult to interpret the meaning of the antibody level (mean channel
value) differences observed in the present study. In particular, the
high antibody levels reported in Table 3 might indicate, with equally
likelihood, prolonged infection, a recent relapse, or chronic disease.
Although determining them was not included among the objectives of the
present study, the changes in antibody isotype (2, 15, 21)
and titer (2) occurring during B. abortus
infection are approaching clinical relevance. By using two
isotype-specific secondary antibodies, one labelled with fluorescein
and the other labelled with phycoerythrin, the DCT can be used to study
antibodies of two different isotypes simultaneously. In addition, as
already discussed, the DCT can assess the antibody level rapidly.
At present, the main limitation of both the SCT and the DCT is the high
cost of the cytometer. However, this instrument, in view of its
versatility, is expected to soon become widely used in many fields, one
being virology. Recently, the simultaneous detection by flow cytometry
of three viruses has been reported (11). The availability of
visible-wavelength diode lasers of low price, high efficiency, and long
lifetime (8) is expected to promote broader applications of
flow cytometry and, consequently, lower prices.
In their present forms, the SCT and DCT can be used in any laboratory
in which a cytometer is available. In addition, both techniques can be
easily adapted to identify antibodies against pathogens other than
S. aureus and B. abortus. The DCT could be the
technique of choice in the case of large-scale eradication programs for
brucellosis. In comparison to the CFT, it can detect a larger fraction
of the animals with circulating antibodies while, at the same time,
providing information about the incidence of mastitis, another disease
that is very costly to the dairy industry.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Chair of
Immunology, School of Agriculture, Via Università 133, Portici,
80055 Naples, Italy. Phone: 81-775-35-14. Fax: 81-776-28-86. E-mail:
Iannelli{at}ds.unina.it.
 |
REFERENCES |
| 1.
|
Alton, G. G.,
L. M. Jones,
R. D. Angus, and J. M. Verger (ed.).
1988.
Techniques for the brucellosis laboratory.
Institut National de la Recherche Agronomique, Paris, France.
|
| 2.
|
Ariza, J.,
T. Pellicer,
R. Pallares,
A. Foz, and F. Gudiol.
1992.
Specific antibody profile in human brucellosis.
Clin. Infect. Dis.
14:131-140[Medline].
|
| 3.
|
Baum, M.,
O. Zamir,
R. Bergman-Rios,
E. Katz,
Z. Beider,
A. Cohen, and M. Banai.
1995.
Comparative evaluation of microagglutination test and serum agglutination test as supplementary diagnostic methods for brucellosis.
J. Clin. Microbiol.
33:2166-2170[Abstract].
|
| 4.
|
Bishop, G. C.,
P. P. Bosman, and S. Herr.
1994.
Bovine brucellosis, p. 1053-1063.
In
J. A. W. Coetzer, G. R. Thompson, and R. C. Tustin (ed.), Infectious diseases of livestock. Oxford University Press, Oxford, United Kingdom.
|
| 5.
|
Clarke, S. M.
1991.
A novel enzyme linked immunosorbent assay (ELISA) for the detection of beryllium antibodies.
J. Immunol. Methods
137:65-72[Medline].
|
| 6.
|
D'Apice, L.,
D. Fenizia,
R. Capparelli,
F. Scala, and D. Iannelli.
1996.
Detection of antibodies to Staphylococcus aureus in water buffalo milk by flow cytometry.
Res. Vet. Sci.
60:179-181[Medline].
|
| 7.
|
Devriese, L. A.,
H. Laevens, and F. Haesebrouck.
1994.
A simple identification scheme for coagulase negative staphylococci from bovine mastitis.
Res. Vet. Sci.
57:240-244[Medline].
|
| 8.
|
Doornbos, R. M.,
B. G. de Grooth,
Y. M. Kraan,
C. J. van der Poel, and J. Greeve.
1994.
Visible diode lasers can be used for flow cytometric immunofluorescence and DNA analysis.
Cytometry
15:267-271[Medline].
|
| 9.
|
Grimont, F.,
J. M. Verger,
P. Cornelis,
J. Limet,
M. Lefevre,
M. Grayon,
B. Regnault,
J. Van Broeck, and P. A. D. Grimont.
1992.
Molecular typing of Brucella with cloned DNA probes.
Res. Microbiol.
143:55-65[Medline].
|
| 10.
|
Hall, S. M., and A. W. Confer.
1987.
Comparison of TRACK XI fluorimetric immunoassay system with other serologic tests for detection of serum antibody to Brucella abortus in cattle.
J. Clin. Microbiol.
25:350-354[Abstract/Free Full Text].
|
| 11.
| Iannelli, D., L. D'Apice, C. Cottone, M. Viscardi, F. Scala, A. Zoina, G. Del Sorbo, P. Spigno, and R. Capparelli.
Simultaneous detection of cucumber mosaic virus, tomato mosaic virus
and potato virus Y by flow cytometry. J. Virol. Methods, in press.
|
| 12.
|
Kapur, V.,
W. M. Sischo,
R. S. Greer,
T. S. Whittam, and J. M. Musser.
1995.
Molecular population genetic analysis of Staphylococcus aureus recovered from cows.
J. Clin. Microbiol.
33:376-380[Abstract].
|
| 13.
|
Miles, H.,
W. Lesser, and P. Sears.
1992.
The economic implications of bioengineered mastitis control.
J. Dairy Sci.
75:596-605[Abstract].
|
| 14.
|
Ministero della Sanità.
1994.
Gazzetta ufficiale della Repubblica Italiana, ser. gen. no. 277. Regolamento concernente il piano nazionale per la eradicazione della brucellosi.
Ministero della Sanità, Rome, Italy.
|
| 15.
|
Pugh, G.,
W. Jr, and L. B. Tabatabai.
1994.
Alteration of protective and serologic responses in BALB/c mice vaccinated with chemically modified versus nonmodified proteins of Brucella abortus 19.
Infect. Immun.
62:5327-5334[Abstract/Free Full Text].
|
| 16.
|
Ruth, S.,
P. C. Drieduck,
R. S. Weening, and T. A. Out.
1991.
ELISA procedures for the measurement of IgG subclass antibodies to bacterial antigens.
J. Immunol. Methods
140:67-78[Medline].
|
| 17.
|
Schalm, O. W., and D. O. Noorlander.
1957.
Experiments and observations leading to the development of the California mastitis test.
J. Am. Vet. Med. Assoc.
130:199-204[Medline].
|
| 18.
|
Schalm, O. W.,
E. J. Carrol, and N. C. Jain.
1975.
Le mastiti della bovina, p. 1-26.
, 172-191. Edagricole, Bologna, Italy.
|
| 19.
|
Schiavo, A.
1990.
Patologia bovina e bufalina e legislazione veterinaria, p. 425-491.
. Bari, Laterza, Italy.
|
| 20.
|
Sischo, W. M.,
L. E. Heider,
G. Y. Miller, and D. A. Moore.
1993.
Prevalence of contagious pathogens of bovine mastitis and use of mastitis control practices.
J. Am. Vet. Med. Assoc.
202:595-600[Medline].
|
| 21.
|
Spencer, T. L., and G. W. Burgess.
1984.
Enzyme-linked immunosorbent assay for Brucella ovis specific antibody in ram sera.
Res. Vet. Sci.
36:194-198[Medline].
|
| 22.
|
Steel, R. G., and J. H. Torrie.
1960.
Principles and procedures of statistics, p. 366-387.
McGraw-Hill Book Company, Inc., New York, N.Y.
|
| 23.
|
Vendrell, J.-P.,
A.-M. Conge,
M. Segondy,
S. Lombroso,
M.-F. Huguet,
A. Bertrand,
F. Janbon, and A. Serre.
1992.
In vitro antibody secretion by peripheral blood mononuclear cells as an expression of the immune response to Brucella spp. in humans.
J. Clin. Microbiol.
30:2200-2203[Abstract/Free Full Text].
|
| 24.
|
Young, E.
1989.
Clinical manifestations of human brucellosis, p. 97-126.
In
E. Young, and M. Corbel (ed.), Brucellosis: clinical and laboratory aspects. CRC Press, Inc., Boca Raton, Fla.
|
Journal of Clinical Microbiology, March 1998, p. 802-806, Vol. 36, No. 3
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Alvarez-Barrientos, A., Arroyo, J., Canton, R., Nombela, C., Sanchez-Perez, M.
(2000). Applications of Flow Cytometry to Clinical Microbiology. Clin. Microbiol. Rev.
13: 167-195
[Abstract]
[Full Text]